Appointment booking for Dr. Praveen Gundelly, MD is currently not available.Dr. Praveen Gundelly, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Praveen Gundelly, MD (he/him) is a Infectious Disease Doctor, Internist in Cleveland, OH with over 16 years of experience. What is your opinion of Dr. Praveen Gundelly, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 16 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Praveen Gundelly, MD has received over $1,729 which includes payments from the following companies:
$281.63 from ViiV Healthcare Company
$248.89 from Merck Sharp & Dohme Corporation
$199.94 from Melinta Therapeutics, Inc.
$187.75 from Gilead Sciences Inc
$129.87 from Insmed, Inc.
$122.32 from Astellas Pharma US Inc
$118.23 from The Medicines Company
$111.02 from Theratechnologies Inc.
$70.56 from Allergan Inc.
$63.76 from Janssen Biotech, Inc.
$61.65 from TETRAPHASE PHARMACEUTICALS, INC.
$50.00 from Novartis Pharmaceuticals Corporation
$27.29 from Cubist Pharmaceuticals Inc
$17.41 from Nabriva Therapeutics, plc
$15.28 from Napo Pharmaceuticals Inc
$12.42 from Vyera Pharmaceuticals, LLC
$11.17 from E.R. Squibb & Sons, L.L.C.
Payments received by Dr. Praveen Gundelly, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!